• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Phytotherapy for BPS. Which products can still be prescribed?].

作者信息

Madersbacher S, Schatzl G, Brössner C, Dreikorn K

机构信息

Abteilung für Urologie und Andrologie, Donauspital, Wien, Osterreich.

出版信息

Urologe A. 2005 May;44(5):513-20. doi: 10.1007/s00120-005-0778-8.

DOI:10.1007/s00120-005-0778-8
PMID:15726313
Abstract

For decades, plant extracts have been amongst to the most popular drugs for lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH)/benign prostatic enlargement (BPE). Only a few of the many published studies meet the criteria of the WHO-BPH consensus conference. The few placebo-controlled, long-term (>/=6 months) studies suggest a positive effect of some extracts (saw palmetto, beta-sitosterol, urtica, rye-grass, saw palmetto/urtica combination) on LUTS; an effect on uroflow, post-void residual volume, prostate volume and PSA was not consistently demonstrable. Randomised trials against an active comparator (alpha1-blocker, 5alpha-reductase inhibitors) are difficult to interpret. Due to the lack of prospective studies, several meta-analyses have been published that can not, however, replace prospective studies. None of the BPH-guidelines currently recommend plant extracts, yet universally conclude that this is an interesting approach. Further prospective studies using WHO standards are required to reliably determine the role of such extracts in the management of elderly men with LUTS due to BPH/BPE.

摘要

相似文献

1
[Phytotherapy for BPS. Which products can still be prescribed?].
Urologe A. 2005 May;44(5):513-20. doi: 10.1007/s00120-005-0778-8.
2
[Phytotherapy of benign prostate syndrome and prostate cancer: better than placebo].[良性前列腺综合征和前列腺癌的植物疗法：优于安慰剂]
Urologe A. 2012 Dec;51(12):1674-82. doi: 10.1007/s00120-012-3033-0.
3
Plant extracts: sense or nonsense?植物提取物：是合理还是无稽之谈？
Curr Opin Urol. 2008 Jan;18(1):16-20. doi: 10.1097/MOU.0b013e3282f0d5c8.
4
Future aspects of plant derived bioactive metabolites as therapeutics to combat benign prostatic hyperplasia.植物源生物活性代谢物作为治疗良性前列腺增生的药物的未来前景。
J Ethnopharmacol. 2024 Aug 10;330:118207. doi: 10.1016/j.jep.2024.118207. Epub 2024 Apr 16.
5
What do I tell patients about saw palmetto for benign prostatic hyperplasia?我应该告诉患有前列腺增生的患者关于锯棕榈的什么信息？
Urol Clin North Am. 2011 Aug;38(3):261-77. doi: 10.1016/j.ucl.2011.04.005.
6
Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study.荨麻治疗良性前列腺增生：一项前瞻性、随机、双盲、安慰剂对照、交叉研究。
J Herb Pharmacother. 2005;5(4):1-11.
7
Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.锯叶棕、硒和番茄红素用于治疗提示良性前列腺增生的下尿路症状。
Expert Opin Drug Saf. 2016 Dec;15(12):1661-1670. doi: 10.1080/14740338.2016.1190830. Epub 2016 Jun 1.
8
A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency.植物甾醇强化型和常规锯棕榈油缓解良性前列腺增生和雄激素缺乏的双盲、安慰剂对照随机比较研究。
BMC Urol. 2020 Jul 3;20(1):86. doi: 10.1186/s12894-020-00648-9.
9
Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms.锯叶棕（锯齿棕）果实提取物和荨麻（异株荨麻）根提取物：良性前列腺增生及相关下尿路症状医学治疗中的可行替代方案。
Planta Med. 2001 Aug;67(6):489-500. doi: 10.1055/s-2001-16496.
10
Saw palmetto for the treatment of men with lower urinary tract symptoms.锯叶棕用于治疗有下尿路症状的男性。
J Urol. 2000 May;163(5):1408-12.

引用本文的文献

1
[Phytotherapy of benign prostate syndrome and prostate cancer: better than placebo].[良性前列腺综合征和前列腺癌的植物疗法：优于安慰剂]
Urologe A. 2012 Dec;51(12):1674-82. doi: 10.1007/s00120-012-3033-0.
2
[Therapy of benign prostate syndrome (BPS): guidelines of the German Urologists (DGU)].[良性前列腺综合征（BPS）的治疗：德国泌尿外科医师协会（DGU）指南]
Urologe A. 2009 Dec;48(12):1503-16. doi: 10.1007/s00120-009-2067-4.
3
[Contemporary medical management of the benign prostatic syndrome].[良性前列腺综合征的当代医学管理]

本文引用的文献

1
EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).欧洲泌尿外科学会（EAU）2004年关于疑似良性前列腺梗阻的男性下尿路症状的评估、治疗及随访指南（BPH指南）
Eur Urol. 2004 Nov;46(5):547-54. doi: 10.1016/j.eururo.2004.07.016.
2
Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia.锯叶棕提取物治疗症状性良性前列腺增生临床试验的更新荟萃分析。
BJU Int. 2004 Apr;93(6):751-6. doi: 10.1111/j.1464-410X.2003.04735.x.
3
[Stinging nettle root extract (Bazoton-uno) in long term treatment of benign prostatic syndrome (BPS). Results of a randomized, double-blind, placebo controlled multicenter study after 12 months].
Urologe A. 2008 Feb;47(2):166-71. doi: 10.1007/s00120-007-1613-1.
4
[Benign prostate hyperplasia: success and limitations of pharmacological therapy].[良性前列腺增生：药物治疗的成功与局限]
Internist (Berl). 2007 Oct;48(10):1157-64. doi: 10.1007/s00108-007-1843-8.
Urologe A. 2004 Mar;43(3):302-6. doi: 10.1007/s00120-004-0532-7.
4
AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations.美国泌尿外科学会良性前列腺增生管理指南（2003年）。第1章：诊断与治疗建议。
J Urol. 2003 Aug;170(2 Pt 1):530-47. doi: 10.1097/01.ju.0000078083.38675.79.
5
[Guidelines of German urologists on therapy of benign prostate syndrome].[德国泌尿科医生良性前列腺综合征治疗指南]
Urologe A. 2003 May;42(5):722-38. doi: 10.1007/s00120-003-0318-3. Epub 2003 Mar 22.
6
[Phytotherapy of benign prostatic hyperplasia. Current evidence-based evaluation].
Urologe A. 2002 Sep;41(5):447-51. doi: 10.1007/s00120-002-0234-y.
7
Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.一种植物治疗剂（爱普列特）与一种α受体阻滞剂（坦索罗辛）治疗良性前列腺增生的比较：一项为期1年的随机国际研究。
Eur Urol. 2002 May;41(5):497-506; discussion 506-7.
8
Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms.针对有下尿路症状男性的锯棕榈随机、双盲、安慰剂对照试验。
Urology. 2001 Dec;58(6):960-4; discussion 964-5. doi: 10.1016/s0090-4295(01)01442-x.
9
Management of lower urinary tract symptoms of elderly men in Austria.奥地利老年男性下尿路症状的管理
Eur Urol. 2001 Feb;39(2):145-50. doi: 10.1159/000052429.
10
Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis.非洲臀果木治疗良性前列腺增生症患者：一项系统评价和定量荟萃分析。
Am J Med. 2000 Dec 1;109(8):654-64. doi: 10.1016/s0002-9343(00)00604-5.